Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer | MicrobiomeTrials

← Back to trials

NCT07673887

A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-06-30Est. Completion: 2031-02-28

Enrollment target: 570 participants

Locations

Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States
Niigata Cancer Center Hospital, Niigata, Japan
Pan American Center for Oncology Trials, Dorado, Puerto Rico

Contact

Astellas Pharma Global Development IncAstellas.registration@astellas.com 800-888-7704

Other microbiome trials you might be interested in

Breath Research Narrow Validation for Gastrointestinal Cancer DetectionRecruiting

Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma

The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…

Maidstone, United KingdomEst. completion Feb 2, 2028

View Trial →

Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.Recruiting

Pancreatic Ductal AdenocarcinomaPancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with high rates of local recurrence and distant metastas…

Minya, EgyptEst. completion Apr 1, 2027

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.